Fu Xiaohang, Liu Yani
Department of Postpartum Rehabilitation, The Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xi'an, China.
Department of Gynecology, The Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Xi'an, China.
Transl Cancer Res. 2021 Dec;10(12):5372-5382. doi: 10.21037/tcr-21-2609.
To evaluate the clinical value of microRNA (miR) and circulating tumor RNA (ctDNA) in the diagnosis of epithelial ovarian cancer (EOC) by meta-analysis and indirect comparison based on common reference criteria.
The PubMed, EMBASE, MEDLINE, Cochrane Library, Chinese biology medicine (CBM), China national knowledge infrastructure (CNKI), Wanfang, and Chinese Weipu (VIP) databases were searched by computer. The retrieval time limit was from the date of establishment of the database to September 2020. Two researchers independently screened the literature and extracted the basic data according to the inclusion and exclusion criteria formulated in advance, and evaluated the literature quality according to the quality assessment of diagnostic accuracy research (quadas-2). The Meta disc 1.4 and Stata 12.0 software programs were used for meta-analysis to calculate the combined sensitivity, combined specificity, combined positive likelihood ratio, combined negative likelihood ratio and combined diagnostic odds ratio (DOR). The summary receiver operating characteristic (SROC) curve was drawn using Revman 5.3 software, and the stability of the results was evaluated by sensitivity analysis. The publication bias was evaluated by Deek's funnel asymmetric test. The relative diagnostic odds ratio (RDOR) results of indirect comparison between microRNA and ctDNA were obtained using R software.
Nineteen articles were included, including a total of 1,351 EOC patients and 1,194 controls. The heterogeneity test showed that there was obvious heterogeneity caused by non-threshold effect. The random effects model was used for meta-analysis of microRNA in the diagnosis of EOC. The results showed that there was no significant difference between microRNA and ctDNA in the accuracy of EOC diagnosis. The asymmetric test of Deek's funnel chart showed that there was no significant publication bias.
There are some limitations in this study, there is no blind diagnostic test, and the intensity of indirect comparison evidence is lower than that of direct comparison evidence. The accuracy of diagnostic tests and the imperfection of mesh meta-analysis statistical methods. MicroRNA and ctDNA have similar clinical diagnostic value for EOC.
通过基于共同参考标准的Meta分析和间接比较,评估微小RNA(miR)和循环肿瘤RNA(ctDNA)在上皮性卵巢癌(EOC)诊断中的临床价值。
通过计算机检索PubMed、EMBASE、MEDLINE、Cochrane图书馆、中国生物医学文献数据库(CBM)、中国知网(CNKI)、万方数据库和维普数据库。检索时间范围为各数据库建库至2020年9月。两名研究人员根据预先制定的纳入和排除标准独立筛选文献并提取基本数据,依据诊断准确性研究的质量评估(quadas-2)对文献质量进行评价。采用Meta disc 1.4和Stata 12.0软件进行Meta分析,计算合并敏感度、合并特异度、合并阳性似然比、合并阴性似然比和合并诊断比值比(DOR)。使用Revman 5.3软件绘制汇总受试者工作特征(SROC)曲线,并通过敏感性分析评估结果的稳定性。采用Deek漏斗不对称检验评估发表偏倚。使用R软件获得miR与ctDNA间接比较的相对诊断比值比(RDOR)结果。
纳入19篇文章,共1351例EOC患者和1194例对照。异质性检验显示存在由非阈值效应引起的明显异质性。采用随机效应模型对miR诊断EOC进行Meta分析。结果显示,miR与ctDNA在EOC诊断准确性方面无显著差异。Deek漏斗图不对称检验显示无显著发表偏倚。
本研究存在一些局限性,未进行盲法诊断试验,间接比较证据的强度低于直接比较证据。诊断试验准确性及网状Meta分析统计方法存在不完善之处。miR和ctDNA对EOC具有相似的临床诊断价值。